GenomeFrontier Therapeutics TW Co., Ltd.
Update：2023/06/12
Industries
Main Industry
Health Care
Main Product/Service
GenomeFrontier’s product pipeline is built around its Quantum Engine™, which integrates four core platforms: Quantum Nufect™ (gentle, efficient gene delivery), Quantum pBac™ (high-capacity non-viral gene integration), iCellar™ (robust cell expansion), and
Founded Year
2018
Unified Business No.
50792421
Status
Active
Number of Employees
0
Total Paid-in
Capital
694,706,939 (NT$)
Location of Company
Taiwan
, New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
GenomeFrontier Therapeutics, Inc. is an innovation-driven gene therapy company based in Taiwan, focused on developing next‑generation virus-free gene and cell therapies. Leveraging four proprietary cell engineering platforms, they have built their core Qu
